Immunometabolism in Pediatric Obesity

NCT03960333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2025-02-13

No results posted yet for this study

Summary

This is a study to learn about obesity and how insulin resistance and Type 2 Diabetes develops in children.

Conditions

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH
  • University of Arkansas

    collaborator OTHER
  • Arkansas Children's Hospital Research Institute

    lead OTHER

Principal Investigators

  • Shannon Rose, PhD · Arkansas Children's Research Institute

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-25
Primary Completion
2021-02-05
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03960333 on ClinicalTrials.gov